Aminosalicylic Acid [kyselina aminosalicylová]
- Terms
-
4-aminosalicylan hlinitý
kyselina p-aminosalicylová
kyselina para-aminosalicylová
p-aminosalicylan draselný
p-aminosalicylan lithný
p-aminosalicylan sodný
p-aminosalicylan sodný, dihydrát
p-aminosalicylan vápenatý
Pamisyl
Rezipas
zásaditý p-aminosalicylan hlinitý (2:1)
-
4-Aminosalicylic Acid
Alumino-4-Aminosalicylic Acid
p-Aminosalicylic Acid
p-Aminosalicylic Acid Monolithium Salt
p-Aminosalicylic Acid Monopotassium Salt
p-Aminosalicylic Acid Monosodium Salt
p-Aminosalicylic Acid, Aluminum (2:1) Salt
p-Aminosalicylic Acid, Calcium (2:1) Salt
p-Aminosalicylic Acid, Monosodium Salt, Dihydrate
Pamisyl
para-Aminosalicylic Acid
Rezipas
An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid.
- Annotation
- AMINOSALICYLIC ACIDS is also available
- DUI
- D010131 MeSH Browser
- CUI
- M0000970
- CAS
- Benzoic acid, 4-amino-2-hydroxy-
- Previous indexing
- Aminosalicylic Acids (1966-1976)
- History note
- 2010, 1963-1976
- Public note
- 2010,1963-1976. see p-Aminocalicylic acid. 1977-2009, see AMINOSALICYLIC ACIDS 1977-90; for PAS see AMINOSALICYCLIC ACID 1963-1967
Combination
- analogs & derivatives
- Aminosalicylic Acids
Allowable subheadings
- AD
- administration & dosage 8
- AE
- adverse effects 2
- AG
- agonists
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood 1
- CF
- cerebrospinal fluid
- CS
- chemical synthesis 1
- CH
- chemistry 1
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 11
- PO
- poisoning
- RE
- radiation effects 1
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 14
- TO
- toxicity
- UR
- urine
Vadrine Chemical MeSH Browser
p-aminosalicylic acid, oxyquinoline drug combination Chemical MeSH Browser